Pradaxa Lawsuit | Side Effects: Serious Internal Bleeding

Pradaxa Lawsuit | Side Effects: Serious Internal Bleeding

Pradaxa Lawsuits | Pradaxa Side Effects, Pradaxa Serious Internal Bleeding | Side effects: Cerebral bleeding, brain hemorrhage, Gastrointestinal hemorrhage, stomach bleeding, intestines bleeding, Renal bleeding, kidney bleeding, Heart attack, Stroke, Wrongful death

pradaxa lawsuit side-effects-lawyer.Pradaxa Lawsuit Information: Where you or someone you love seriously injured by the blood thinner Pradaxa? Thousands of Pradaxa lawsuit plaintiffs have already received compensation for internal bleeding and related complications allegedly associated with its use. Yet the litigation is far from over, as Pradaxa lawsuit bleeding claims continue to mount in courts around the country.

Southern Med Law is evaluating potential Pradaxa lawsuits for bleeding-related complications that occurred between May 2014 and October 2015, including those involving:

  • Cerebral bleeding (brain hemorrhage)
  • Gastrointestinal hemorrhage (bleeding in the stomach or intestines)
  • Renal bleeding (kidneys)
  • Heart attack
  • Stroke
  • Wrongful death due to Pradaxa-related hemorrhage

As both an attorney and practicing physician, Dr. François Blaudeau possesses a unique understanding of the medical and legal issues at the center of the Pradaxa litigation. If you are interested in pursuing a Pradaxa bleeding lawsuit on behalf of yourself or a loved one, please contact Dr. Blaudeau and his colleagues at Southern Med Law to learn more about your legal rights today and your ability to file a Pradaxa lawsuit.

Pradaxa Lawsuits and Litigation

The first Pradaxa lawsuits alleging wrongful death were filed in 2010, shortly after the medication came on the market. Eventually, thousands of cases would be filed on behalf of patients who allegedly experienced serious and often deadly Pradaxa bleeding complications. In August 2012, all federal Pradaxa lawsuits were centralized in a multidistrict litigation and transferred to a single judge in the U.S. District Court, Southern District of Illinois.

In May 2014, Boehringer Ingelheim agreed to pay $650 million to settle all 4,000 Pradaxa lawsuits pending against the company. However, the settlement only provided compensation to those who had already filed a claim. Pradaxa patients who experienced a bleeding-related adverse event between May 2014 and October 2015 may still be able to file a Pradaxa lawsuit of their own.

FDA adverse event data indicates 932 reports of serious Pradaxa bleeding events in six months

FDA adverse event data indicates that the agency received 932 reports of serious Pradaxa bleeding events between the drug’s October 2010 approval and March 2011. By 2012, more than 500 deaths had been attributed to the drug. Two years later, the number of fatalities linked to Pradaxa had reached 1,000.

What is Pradaxa?

Pradaxa (dabigatran) was approved by the U.S. Food & Drug Administration (FDA) in 2010 to prevent strokes in people with atrial fibrillation. From the start, Boehringer Ingelheim touted the drug as a superior alternative to warfarin, a blood thinner sold under the brand name Coumadin. Warfarin has been on the market for decades, and has long been the standard anticoagulant treatment. However, patients using warfarin must undergo regular blood testing and submit to certain dietary restrictions. Pradaxa required neither, making it an attractive alternative to many. By 2012, the new blood thinner had been prescribed to roughly 725,000 patients in the United States.

Unfortunately, claims of Pradaxa’s superiority may have been overblown. While internal bleeding can occur with any anticoagulant, warfarin bleeding can be brought under control via the administration of vitamin K. By contrast, the FDA did not approve an antidote for Pradaxa bleeding until October 2015 – five years after the medication came on the market. More than a year earlier, a report published in the British Medical Journal (BMJ) alleged that Boehringer Ingelheim had withheld crucial data suggesting that regular monitoring of their plasma levels would actually improve outcomes for Pradaxa patients.

Legal Help for Victims of Pradaxa Bleeding Injuries

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made Southern Med Law an aggressive and effective advocate for those who were harmed due to negligent pharmaceutical manufacturers. If you or a loved one experienced a serious Pradaxa bleeding event, please contact Southern Med Law today to learn more about your legal rights. You can arrange for a free, no obligation Pradaxa lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.